FDA Physician Survey Would Collect Info On Risk Communications
This article was originally published in The Pink Sheet Daily
Proposed survey seeks to understand when and how physicians like to receive risk information about drug products.
You may also be interested in...
The effort would be overseen by new Associate Center Director for Safety Policy & Communication Paul Seligman.
The company released an annual pricing report, showing that Sanofi's US average net prices declined for the fifth year in a row.
The firm’s acute migraine treatment Nurtec ODT generated $65m in 2020 after launching a year ago. Biohaven aims for Nurtec to become the leader in what could be a $4bn-$5bn category in the US.